Chandler Park, Medical Doctor, Masters in Science
Dr. Park is a practicing genitourinary oncologist and clinical researcher. He is the co-director
of genitourinary research at Norton Cancer Institute that focuses on renal cell cancer, bladder
cancer and prostate cancer.
He is an advisory dean and clinical professor at the University of Louisville School of Medicine.
He completed his medical school at the University of Louisville School of Medicine, Internal
Medicine internship at Cleveland Clinic, residency at Indiana University, Hematology/Oncology
fellowship at West Virginia University, and immunotherapy visiting fellowship at University of
Pittsburgh.
He is co-director of the genitourinary oncology research trials at Norton Cancer Institute. Most
recently he was a Principal Investigator and leading enrollers for key clinical GU clinical trials
including ARASENS, VISION, EV-301, TROPHY U-01 et al.
Dr. Park has been published in numerous manuscripts, journal articles, and book chapters
including publications in New England Journal of Medicine, Journal of Clinical Oncology,
Lancet Oncology, Blood Journal etc. He also volunteers as a member of the physician medical
board for Doximity. He also hosts podcasts on OncLive Unplugged and OncoDaily.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AstellasTopic:ResearchDate added:11/10/2024Date updated:11/10/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AstraZenecaTopic:ResearchDate added:11/10/2024Date updated:11/10/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BayerTopic:ResearchDate added:11/10/2024Date updated:11/10/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Bristol Myers SquibbTopic:ResearchDate added:11/10/2024Date updated:11/10/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:ExelexisTopic:ResearchDate added:11/10/2024Date updated:11/10/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:GenentechTopic:ResearchDate added:11/10/2024Date updated:11/10/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:GileadTopic:ResearchDate added:11/10/2024Date updated:11/10/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:JanssenTopic:ResearchDate added:11/10/2024Date updated:11/10/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:PfizerTopic:ResearchDate added:11/10/2024Date updated:11/10/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:RocheTopic:ResearchDate added:11/10/2024Date updated:11/10/2024